Focused Issue on Predictive and Prognostic Biomarkers in Tumors

Posted On 2019-07-15 01:16:00


This focused issue on “Predictive and Prognostic Biomarkers in Tumors” is edited by Dr. Mari Mino-Kenudson, from Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; and Dr. Yin (Rex) P. Hung, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Dr. Mari Mino-Kenudson was trained as a Pulmonary Medicine resident and fellow after graduating from Kyoto University, Faculty of Medicine, Kyoto, Japan, and worked as a staff Pulmonologist at Tenri Hospital, Nara, Japan for several years. Then, she changed her career from Pulmonary Medicine to Pathology. After completing Pathology residency and fellowship, she came on staff at Department of Pathology, at MGH in 2004. She has been conducting translational research on lung cancer in collaboration with molecular pathologists, thoracic oncologists, thoracic surgeons and basic scientists.

Dr. Yin (Rex) P. Hung is a diagnostic specialist in pulmonary, cardiovascular, and bone and soft tissue pathology at Massachusetts General Hospital. His clinical practice and research focus include mesothelioma, lung cancer, and sarcomas.

Focused issue outline:

  1. Preface to this focused issue
    Mari Mino-Kenudson and Yin (Rex) P. Hung, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
  2. Lung cancer
    Yin (Rex) P. Hung and Mari Mino-Kenudson, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  3. Head and neck tumors
    Sara Pai, Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
  4. Skin tumors    
    Rosalynn Nazarian, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  5. Brain tumors
    Wesley Samore, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Maria Martinez-Lage, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, USA
  6. Microsatellite instability    
    Elizabeth Wu and Murray Resnick, Department of Pathology, Rhode Island Hospital and Lifespan Medical Center, Providence, RI, USA
  7. NTRK alterations
    Yin (Rex) P. Hung, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Anna Farago, Massachusetts General Hospital, Cancer Center and Department of Medicine, Boston, MA, USA
  8. BRAF alterations    
    Lynette Sholl, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
  9. Biomarkers of checkpoint inhibitors
    Mari Mino-kenudson, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA